1
|
Zou T, Huang Y, Hu Y, Wu M, Zhao Y, Du F, Li M, Wu X, Ji H, Kaboli PJ, Wang S, Xiao Z, Wu Z. Study on the Anti-Tumor Mechanism and Target of Triptolide based on Network Pharmacology and Molecular Docking. Recent Pat Anticancer Drug Discov 2021; 16:426-435. [PMID: 33573560 DOI: 10.2174/1574892816666210211143059] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2020] [Revised: 11/30/2020] [Accepted: 12/30/2020] [Indexed: 11/22/2022]
Abstract
BACKGROUND According to the special physiological and pharmacological activities of natural compounds, many drugs with special therapeutic effects have been developed. The triptolide (TP) is a kind of natural anti-tumor drug with a world patent, but its target and mechanism are yet not known. OBJECTIVE The study aims to explore and predict the target and mechanism of TP on non-small cell lung cancer (NSCLC), pancreatic cancer (PC) and colorectal cancer (CC) through network pharmacology technology. METHODS We screened the core targets of TP with NSCLC, PC and CC, respectively, and carried out network analysis, enrichment analysis and ligand-receptor docking to clarify its potential pharmacological mechanism. RESULTS By screening the core genes between TP with NSCLC, PC and CC, respectively, it was found that PTGS2 was the common target gene in the three cancers. NSCLC, CCL2, IL6, HMOX1 and COL1A1 are the specific target genes, while MMP2, JUN, and CXCL8 are the specific target genes in PC. In CC, the specific target genes includeERBB2, VEGFA, STAT1 andMAPK8. In enrichment analysis, it was found that the NF- κB, toll-like receptors and IL-17 signaling pathway were mainly involved in TP for these cancers. The binding energy of TP to the core target is less than that of cyclophosphamide. CONCLUSIONS This study preliminarily revealed that TP may prevent and treat cancers\ through multiple targets and pathways. The possible mechanisms of TP include regulating immune and inflammatory responses, promoting apoptosis and inhibiting tumor development. It shows that TP may have a potential in treating kinds of tumors.
Collapse
Affiliation(s)
- Tao Zou
- Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000. China
| | - Yuanqiong Huang
- Department of Nephropathy, Luzhou Traditional Chinese Medicine Hospital, Luzhou 646000. China
| | - Yifan Hu
- Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000. China
| | - Mingyu Wu
- Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000. China
| | - Yueshui Zhao
- Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000. China
| | - Fukuan Du
- Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000. China
| | - Mingxing Li
- Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000. China
| | - Xu Wu
- Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000. China
| | - Huijiao Ji
- Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000. China
| | - Parham Jabbarzadeh Kaboli
- Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000. China
| | - Shurong Wang
- Department of Pharmacy, the Affiliated Hospital of Southwest Medical University, Luzhou 646000, Sichuan, China;, Luzhou 646000. China
| | - Zhangang Xiao
- Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000. China
| | - Zhigui Wu
- Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000. China
| |
Collapse
|
2
|
Du X, Nyagblordzro M, An L, Gao X, Du L, Wang Y, Ondieki G, Kikete S, He X. Pharmacokinetic and Toxicological Characteristics of Tripterigium Glycosides and Their Derivatives. Curr Drug Metab 2018; 19:605-627. [PMID: 29512444 DOI: 10.2174/1389200219666180302152752] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2017] [Revised: 11/16/2017] [Accepted: 12/03/2017] [Indexed: 11/22/2022]
Abstract
BACKGROUND Tripterigium wilfordii glycosides (TWG) demonstrate paramount bioactive effectiveness in the management of many autoimmune diseases. However, its side effects on the hepatic, nephrotic, reproductive, and cardiovascular systems have limited its immense therapeutic potentials. Triptolide (TP) and Celastrol (CL), the leading bioactive as well as toxic constituents of TWG, have been widely studied. This review aims to summarize the key mechanisms that TWG trigger the toxic reactions and the precautionary measures that could prevent and reduce such reactions. METHOD We undertook a systemic search of bibliographic databases for peer-reviewed research literature about the toxic mechanisms and pharmacokinetic profiles of TWG. The key points of screened papers were described and combined together to make up whole. RESULTS Totally 125 papers were referred in this paper, the majority were from Chinese academic associations. It has been reported that reactive oxygen species generation, mitochondrial respiratory chain inhibition, and metabolizing enzyme inhibition are the leading factors of the toxic reactions. The bioactive effects and toxicities of TWG are closely related to its metabolic profiles. It has been confirmed that TP and CL inhibit CYP450 and the transporters. This paper reviews and summarizes the pharmacokinetic parameters of TWG. Antioxidants, polymeric micelle and topical nanoparticle formulations have exhibited potentials in toxicity circumvention. CONCLUSION A thorough understanding of the pharmacokinetic and toxicological characteristics of TWG combined with further in-depth study will enhance the efficacy and safety in using TWG, which would augment and improve its clinical application in the future.
Collapse
Affiliation(s)
- Xi Du
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin-300193, China.,Second Affiliated Hospital of Tianjin University of TCM, Tianjin-300150, China
| | - Makafui Nyagblordzro
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin-300193, China
| | - Lijun An
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin-300193, China
| | - Xue Gao
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin-300193, China
| | - Lemei Du
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin-300193, China
| | - Yangyang Wang
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin-300193, China
| | - Gregory Ondieki
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin-300193, China
| | - Siambi Kikete
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin-300193, China
| | - Xin He
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin-300193, China.,Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin-300193, China
| |
Collapse
|